According to OPKO Health
's latest financial reports the company has $95.88 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $95.88 M | -37.41% |
2022-12-31 | $0.15 B | 13.72% |
2021-12-31 | $0.13 B | 86.55% |
2020-12-31 | $72.21 M | -15.5% |
2019-12-31 | $85.45 M | -11.42% |
2018-12-31 | $96.47 M | 5.44% |
2017-12-31 | $91.49 M | -45.77% |
2016-12-31 | $0.16 B | -12.84% |
2015-12-31 | $0.19 B | 99.78% |
2014-12-31 | $96.9 M | -47.84% |
2013-12-31 | $0.18 B | 579.06% |
2012-12-31 | $27.36 M | -61.74% |
2011-12-31 | $71.51 M | 296.96% |
2010-12-31 | $18.01 M | -57.77% |
2009-12-31 | $42.65 M | 538.78% |
2008-12-31 | $6.67 M | -71.43% |
2007-12-31 | $23.37 M | 20049.14% |
2006-12-31 | $0.11 M | -98.7% |
2005-12-31 | $8.9 M | -9.71% |
2004-12-31 | $9.85 M | -2.7% |
2003-12-31 | $10.13 M | -37.43% |
2002-12-31 | $16.19 M | 7.98% |
2001-12-31 | $14.99 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $22.92 B | 23,811.93% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $7.27 B | 7,491.70% | ๐บ๐ธ USA |
Regeneron Pharmaceuticals REGN | $10.84 B | 11,210.69% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $12.28 B | 12,707.54% | ๐บ๐ธ USA |
LabCorp LH | $0.53 B | 459.86% | ๐บ๐ธ USA |
Alnylam Pharmaceuticals
ALNY | $2.43 B | 2,444.17% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $3.22 B | 3,264.59% | ๐ฎ๐ฑ Israel |
Ardelyx ARDX | $0.18 B | 92.22% | ๐บ๐ธ USA |